{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:18:19Z","timestamp":1792653499678,"version":"4.5.0"},"reference-count":54,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>The use of benzodiazepine receptor agonists (BZRA) poses serious health risks to older adults. Although several guidelines recommend deprescribing, implementation in clinical practice remains limited.<\/jats:p><\/jats:sec>Objective<\/jats:title>To identify physicians\u2019 barriers to and enablers of deprescribing BZRA in adults aged 65 years and older taking a BZRA for sleep problems; to determine factors associated with hospital physicians\u2019 intention to deprescribe BZRA and their self-reported routine BZRA deprescribing.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This survey study included hospital physicians and general practitioners (GPs) working across 6 European Countries (Belgium, Greece, Norway, Poland, Spain, and Switzerland) between December 2022 and March 2023.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Barriers identification via a 35-item questionnaire based upon the Theoretical Domains Framework (TDF). Responses were categorized as major barriers, moderate barriers, and enablers based on their mean scores. Multivariable logistic regressions were used to identify background characteristics and TDF-based domains associated with hospital physicians\u2019 intention to deprescribe and self-reported routine deprescribing.<\/jats:p><\/jats:sec>Results<\/jats:title>Questionnaires from 240 hospital physicians and 96 GPs were analyzed. Most participants were women: 144 (61.0%) hospital physicians and 52 (54.2%) GPs. In terms of experience, the most common reported time in practice was less than 5 years for hospital physicians (76 [31.7%]) and between 10 and 14 years for GPs (35 [36.5%]). Most reported deprescribing BZRA routinely (135 hospital physicians [57.2%] and 66 GPs [72.5%]). Major barriers (and TDF domains) were similar for hospital physicians and GPs across the 6 countries. These barriers included: lack of training (skills), low self-efficacy (beliefs about capabilities), prioritization of other health issues (goals), frustration with the challenges of deprescribing (emotions), insufficient staff and time, absence of local policies (environmental context and resources), and reluctance from patients (social influence). Intention to deprescribe was significantly associated with country, occupation type, and 5 TDF domains: memory, attention, and decision process (odds ratio [OR], 1.70; 95% Ci, 1.22-2.40); social and\/or professional role and identity (OR, 5.92; 95% CI, 3.28-11.07); beliefs about capabilities (OR, 2.35; 95% CI, 1.55-3.63); beliefs about consequences (OR, 3.00; 95% CI, 1.61-5.71); and reinforcement (OR, 1.49; 95% CI, 1.05-2.15). Routine deprescribing was significantly associated with 3 TDF domains: memory, attention, and decision processes; intentions; and emotions.<\/jats:p><\/jats:sec>Conclusion<\/jats:title>In this theory-based survey study of physicians, physicians and general practitioners described numerous barriers to deprescribing BZRA in older adults. Our findings indicate that effective deprescribing efforts require approaches that address both reflective processes (eg, enhancing capability) and impulsive processes (eg, managing emotions).<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2024.59883","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T16:03:34Z","timestamp":1741017814000},"page":"e2459883","source":"Crossref","is-referenced-by-count":28,"title":["Barriers to Deprescribing Benzodiazepines in Older Adults in a Survey of European Physicians"],"prefix":"10.1001","volume":"8","author":[{"given":"Vladyslav","family":"Shapoval","sequence":"first","affiliation":[{"name":"Clinical Pharmacy and Pharmacoepidemiology Research Group, Louvain Drug Research Institute, Universit\u00e9 catholique de Louvain (UCLouvain), Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"de Saint Hubert","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, CHU UCLouvain Namur, Yvoir, Belgium"},{"name":"Institute of Health and Society (IRSS), UCLouvain, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perrine","family":"Evrard","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy and Pharmacoepidemiology Research Group, Louvain Drug Research Institute, Universit\u00e9 catholique de Louvain (UCLouvain), Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois-Xavier","family":"Sibille","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy and Pharmacoepidemiology Research Group, Louvain Drug Research Institute, Universit\u00e9 catholique de Louvain (UCLouvain), Brussels, Belgium"},{"name":"Department of Geriatric Medicine, CHU UCLouvain Namur, Yvoir, Belgium"},{"name":"Institute of Health and Society (IRSS), UCLouvain, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole E.","family":"Aubert","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland"},{"name":"Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Bolt","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland"},{"name":"Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vagioula","family":"Tsoutsi","sequence":"additional","affiliation":[{"name":"Sleep Research Unit, First Department of Psychiatry, Eginition Hospital, Medical School, National & Kapodistrian University of Athens, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinelopi","family":"Kollia","sequence":"additional","affiliation":[{"name":"Sleep Research Unit, First Department of Psychiatry, Eginition Hospital, Medical School, National & Kapodistrian University of Athens, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Salv\u00e0","sequence":"additional","affiliation":[{"name":"Fundaci\u00f3 Salut i Envelliment UAB Universitat Autonoma de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Miralles","sequence":"additional","affiliation":[{"name":"Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Wichniak","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurophysiology, Sleep Medicine Center, Institute of Psychiatry and Neurology, Warsaw, Poland"},{"name":"Third Department of Psychiatry, Institute of Psychiatry and Neurology, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Gustavsson","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurophysiology, Sleep Medicine Center, Institute of Psychiatry and Neurology, Warsaw, Poland"},{"name":"Department of Science and Evaluation, Medical Research Agency, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torgeir","family":"Bruun Wyller","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Oslo University Hospital, Oslo, Norway"},{"name":"Institute of Clinical Medicine, University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Callegari","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Oslo University Hospital, Oslo, Norway"},{"name":"Department of Old Age Psychiatry, \u00d8stfold Hospital Trust, Gr\u00e5lum, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy M.","family":"Grimshaw","sequence":"additional","affiliation":[{"name":"Methodological and Implementation Research, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"},{"name":"Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Presseau","sequence":"additional","affiliation":[{"name":"Methodological and Implementation Research, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"},{"name":"School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Henrard","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy and Pharmacoepidemiology Research Group, Louvain Drug Research Institute, Universit\u00e9 catholique de Louvain (UCLouvain), Brussels, Belgium"},{"name":"Institute of Health and Society (IRSS), UCLouvain, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Spinewine","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy and Pharmacoepidemiology Research Group, Louvain Drug Research Institute, Universit\u00e9 catholique de Louvain (UCLouvain), Brussels, Belgium"},{"name":"Pharmacy Department, CHU UCLouvain Namur, Yvoir, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,3,3]]},"reference":[{"issue":"1","key":"zoi241671r2","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1186\/s12877-022-03165-6","article-title":"Falls, healthcare resources and costs in older adults with insomnia treated with zolpidem, trazodone, or benzodiazepines.","volume":"22","author":"Amari","year":"2022","journal-title":"BMC Geriatr"},{"issue":"2","key":"zoi241671r3","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1183\/09031936.00008014","article-title":"Benzodiazepine drug use and adverse respiratory outcomes among older adults with COPD.","volume":"44","author":"Vozoris","year":"2014","journal-title":"Eur Respir J"},{"issue":"10","key":"zoi241671r4","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1002\/phar.2170","article-title":"Association between development of dementia and use of benzodiazepines: a systematic review and meta-analysis.","volume":"38","author":"Lucchetta","year":"2018","journal-title":"Pharmacotherapy"},{"issue":"7","key":"zoi241671r5","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1111\/jgs.18372","article-title":"American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults.","volume":"71","author":"By the 2023 American Geriatrics Society Beers Criteria Update Expert Panel","year":"2023","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"zoi241671r6","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s41999-023-00777-y","article-title":"STOPP\/START criteria for potentially inappropriate prescribing in older people: version 3.","volume":"14","author":"O\u2019Mahony","year":"2023","journal-title":"Eur Geriatr Med"},{"issue":"6","key":"zoi241671r7","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.14035","article-title":"The European Insomnia Guideline: an update on the diagnosis and treatment of insomnia 2023.","volume":"32","author":"Riemann","year":"2023","journal-title":"J Sleep Res"},{"issue":"1","key":"zoi241671r8","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s12877-024-04742-7","article-title":"Prevalence, country-specific prescribing patterns and determinants of benzodiazepine use in community-residing older adults in 7 European countries.","volume":"24","author":"Lukaci\u0161inov\u00e1","year":"2024","journal-title":"BMC Geriatr"},{"issue":"8","key":"zoi241671r9","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.eurpsy.2015.09.003","article-title":"Long-term use of benzodiazepines: Definitions, prevalence and usage patterns\u2014a systematic review of register-based studies.","volume":"30","author":"Kurko","year":"2015","journal-title":"Eur Psychiatr"},{"key":"zoi241671r10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/pds.3825","article-title":"Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU Project.","volume":"25","author":"Huerta","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"10","key":"zoi241671r11","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s40266-023-01057-x","article-title":"Trajectories of benzodiazepine use among older adults from a concordance-with-guidelines perspective: a nationwide cohort study.","volume":"40","author":"Maumus-Robert","year":"2023","journal-title":"Drugs Aging"},{"issue":"9","key":"zoi241671r12","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1111\/jgs.18943","article-title":"Assessing the prevalence of Beers medication utilization in the Medicare Part D population in 2020.","volume":"72","author":"Borrelli","year":"2024","journal-title":"J American Geriatrics Society"},{"issue":"12","key":"zoi241671r13","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1111\/jgs.16751","article-title":"Benzodiazepine use and deprescribing in Belgian Nursing Homes: results from the COME-ON Study.","volume":"68","author":"Evrard","year":"2020","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"zoi241671r14","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s40266-023-01029-1","article-title":"Benzodiazepine receptor agonists use and cessation among multimorbid older adults with polypharmacy: secondary analysis from the OPERAM Trial.","volume":"40","author":"Sibille","year":"2023","journal-title":"Drugs Aging"},{"issue":"5","key":"zoi241671r15","first-page":"339","article-title":"Deprescribing benzodiazepine receptor agonists: evidence-based clinical practice guideline.","volume":"64","author":"Pottie","year":"2018","journal-title":"Can Fam Physician"},{"issue":"9391","key":"zoi241671r17","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/S0140-6736(03)14546-1","article-title":"From best evidence to best practice: effective implementation of change in patients\u2019 care.","volume":"362","author":"Grol","year":"2003","journal-title":"Lancet"},{"issue":"5","key":"zoi241671r18","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1136\/bmjqs-2019-010060","article-title":"De-implementing wisely: developing the evidence base to reduce low-value care.","volume":"29","author":"Grimshaw","year":"2020","journal-title":"BMJ Qual Saf"},{"issue":"10","key":"zoi241671r19","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsad124","article-title":"Global trends in the consumption of benzodiazepines and Z-drugs in 67 countries and regions from 2008 to 2018: a sales data analysis.","volume":"46","author":"Ma","year":"2023","journal-title":"Sleep"},{"issue":"1","key":"zoi241671r20","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12875-016-0551-7","article-title":"Factors influencing deprescribing for residents in advanced care facilities: insights from general practitioners in Australia and Sweden.","volume":"17","author":"Bolmsj\u00f6","year":"2016","journal-title":"BMC Fam Pract"},{"issue":"1","key":"zoi241671r21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12877-020-01953-6","article-title":"General practitioners\u2019 deprescribing decisions in older adults with polypharmacy: a case vignette study in 31 countries.","volume":"21","author":"Jungo","year":"2021","journal-title":"BMC Geriatr"},{"issue":"1","key":"zoi241671r22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13012-022-01206-7","article-title":"Barriers and enablers for deprescribing benzodiazepine receptor agonists in older adults: a systematic review of qualitative and quantitative studies using the theoretical domains framework.","volume":"17","author":"Evrard","year":"2022","journal-title":"Implement Sci"},{"issue":"20","key":"zoi241671r23","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"1","key":"zoi241671r24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13012-017-0605-9","article-title":"A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems.","volume":"12","author":"Atkins","year":"2017","journal-title":"Implement Sci"},{"issue":"3","key":"zoi241671r25","doi-asserted-by":"publisher","DOI":"10.1093\/intqhc\/mzab106","article-title":"How is the Theoretical Domains Framework applied in designing interventions to support healthcare practitioner behaviour change? A systematic review.","volume":"33","author":"Dyson","year":"2021","journal-title":"Int J Qual Health Care"},{"issue":"1","key":"zoi241671r26","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s43058-021-00221-x","article-title":"Initial validation of a self-report questionnaire based on the Theoretical Domains Framework: determinants of clinician adoption of a novel colorectal cancer screening strategy.","volume":"2","author":"Zhu","year":"2021","journal-title":"Implement Sci Commun"},{"issue":"1","key":"zoi241671r27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1748-5908-9-11","article-title":"Discriminant content validity of a Theoretical Domains Framework questionnaire for use in implementation research.","volume":"9","author":"Huijg","year":"2014","journal-title":"Implement Sci"},{"issue":"5","key":"zoi241671r28","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1001\/jamainternmed.2015.0324","article-title":"Reducing inappropriate polypharmacy: the process of deprescribing.","volume":"175","author":"Scott","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"5","key":"zoi241671r29","doi-asserted-by":"publisher","first-page":"S80","DOI":"10.4103\/sja.SJA_203_17","article-title":"Guidelines for developing, translating, and validating a questionnaire in perioperative and pain medicine.","volume":"11","author":"Tsang","year":"2017","journal-title":"Saudi J Anaesth"},{"issue":"12","key":"zoi241671r30","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/0895-4356(93)90142-N","article-title":"Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines.","volume":"46","author":"Guillemin","year":"1993","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"zoi241671r31","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-066234","article-title":"Identifying barriers and facilitators to deprescribing benzodiazepines and sedative hypnotics in the hospital setting using the Theoretical Domains Framework and the Capability, Opportunity, Motivation and Behaviour (COM-B) Model: a qualitative study.","volume":"13","author":"Keller","year":"2023","journal-title":"BMJ Open"},{"key":"zoi241671r32","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2147\/PPA.S48357","article-title":"Identification of drug-related problems of elderly patients discharged from hospital.","volume":"8","author":"Hugtenburg","year":"2014","journal-title":"Patient Preference Adherence"},{"issue":"4","key":"zoi241671r33","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1093\/ageing\/afq045","article-title":"Drug-related problems in older people after hospital discharge and interventions to reduce them.","volume":"39","author":"Garcia-Caballos","year":"2010","journal-title":"Age Ageing"},{"issue":"5","key":"zoi241671r34","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1093\/gerona\/glab222","article-title":"Consumer attitudes towards deprescribing: a systematic review and meta-analysis.","volume":"77","author":"Weir","year":"2022","journal-title":"J Gerontol Series A"},{"key":"zoi241671r35","doi-asserted-by":"publisher","DOI":"10.1016\/j.rcsop.2023.100328","article-title":"The role of pharmacists in deprescribing benzodiazepines: a scoping review.","volume":"12","author":"Ashkanani","year":"2023","journal-title":"Explor Res Clin Soc Pharm"},{"issue":"2","key":"zoi241671r36","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/bcp.14947","article-title":"Community-based pharmacists\u2019 role in deprescribing: a systematic review.","volume":"88","author":"Bu\u017eancic","year":"2022","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"zoi241671r37","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.12967","article-title":"The European Academy for Cognitive Behavioural Therapy for Insomnia: an initiative of the European Insomnia Network to promote implementation and dissemination of treatment.","volume":"29","author":"Baglioni","year":"2020","journal-title":"J Sleep Res"},{"issue":"573","key":"zoi241671r38","doi-asserted-by":"publisher","first-page":"e156","DOI":"10.3399\/bjgp10X483922","article-title":"Psychotropic drug use among older people in general practice: discrepancies between opinion and practice.","volume":"60","author":"Lasserre","year":"2010","journal-title":"Br J Gen Pract"},{"issue":"4","key":"zoi241671r39","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3390\/metabo11040254","article-title":"The barriers and facilitators of different stakeholders when deprescribing benzodiazepine receptor agonists in older patients\u2014a systematic review.","volume":"11","author":"Rasmussen","year":"2021","journal-title":"Metabolites"},{"issue":"7121","key":"zoi241671r40","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1136\/bmj.315.7121.1482","article-title":"Pressure to prescribe.","volume":"315","author":"Greenhalgh","year":"1997","journal-title":"BMJ"},{"issue":"7522","key":"zoi241671r41","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1136\/bmj.38551.410012.06","article-title":"Appropriateness of use of medicines in elderly inpatients: qualitative study.","volume":"331","author":"Spinewine","year":"2005","journal-title":"BMJ"},{"issue":"7107","key":"zoi241671r42","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1136\/bmj.315.7107.520","article-title":"Prescribing behaviour in clinical practice: patients\u2019 expectations and doctors\u2019 perceptions of patients\u2019 expectations\u2013a questionnaire study.","volume":"315","author":"Cockburn","year":"1997","journal-title":"BMJ"},{"issue":"2","key":"zoi241671r43","doi-asserted-by":"publisher","first-page":"990","DOI":"10.18549\/PharmPract.2017.02.990","article-title":"Models and theories of prescribing decisions: a review and suggested a new model.","volume":"15","author":"Murshid","year":"2017","journal-title":"Pharm Pract (Granada)"},{"issue":"7437","key":"zoi241671r44","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1136\/bmj.38013.644086.7C","article-title":"Importance of patient pressure and perceived pressure and perceived medical need for investigations, referral, and prescribing in primary care: nested observational study.","volume":"328","author":"Little","year":"2004","journal-title":"BMJ"},{"issue":"3","key":"zoi241671r45","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s12160-014-9609-8","article-title":"Reflective and automatic processes in health care professional behaviour: a dual process model tested across multiple behaviours.","volume":"48","author":"Presseau","year":"2014","journal-title":"Ann Behav Med"},{"issue":"3","key":"zoi241671r46","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1207\/s15327957pspr0803_1","article-title":"Reflective and impulsive determinants of social behavior.","volume":"8","author":"Strack","year":"2004","journal-title":"Pers Soc Psychol Rev"},{"issue":"1","key":"zoi241671r47","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1146\/annurev.psych.59.103006.093629","article-title":"Dual-processing accounts of reasoning, judgment, and social cognition.","volume":"59","author":"Evans","year":"2008","journal-title":"Annu Rev Psychol"},{"issue":"1","key":"zoi241671r48","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/jep.12855","article-title":"How the dual process model of human cognition can inform efforts to de-implement ineffective and harmful clinical practices: a preliminary model of unlearning and substitution.","volume":"24","author":"Helfrich","year":"2018","journal-title":"J Eval Clin Pract"},{"key":"zoi241671r49","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2022.114840","article-title":"Changing healthcare professionals\u2019 non-reflective processes to improve the quality of care.","volume":"298","author":"Potthoff","year":"2022","journal-title":"Soc Sci Med"},{"issue":"4","key":"zoi241671r50","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s40266-018-0536-4","article-title":"Impact of deprescribing interventions in older hospitalised patients on prescribing and clinical outcomes: a systematic review of randomised trials.","volume":"35","author":"Thillainadesan","year":"2018","journal-title":"Drugs Aging"},{"issue":"3","key":"zoi241671r51","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1001\/jamainternmed.2021.7429","article-title":"The MedSafer study\u2014electronic decision support for deprescribing in hospitalized older adults: a cluster randomized clinical trial.","volume":"182","author":"McDonald","year":"2022","journal-title":"JAMA Intern Med"},{"issue":"2","key":"zoi241671r52","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jclinepi.2004.09.002","article-title":"Changing the behavior of healthcare professionals: the use of theory in promoting the uptake of research findings.","volume":"58","author":"Eccles","year":"2005","journal-title":"J Clin Epidemiol"},{"key":"zoi241671r53","doi-asserted-by":"publisher","first-page":"n2061","DOI":"10.1136\/bmj.n2061","article-title":"A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance.","volume":"374","author":"Skivington","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"zoi241671r54","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13012-017-0557-0","article-title":"Use of theory to plan or evaluate guideline implementation among physicians: a scoping review.","volume":"12","author":"Liang","year":"2017","journal-title":"Implement Sci"},{"key":"zoi241671r1","first-page":"e0174730","article-title":"Benzodiazepines, Z-drugs and the risk of hip fracture: a systematic review and meta-analysis.","volume-title":"PLoS ONE","author":"Donnelly","year":"2017"},{"key":"zoi241671r16","unstructured":"Agoritsas? T, Kumbargere Nagraj? S, Callegari? E, Johansson? M. BE-SAFE: Deprescription of benzodiazepine and sedative hypnotics (BSHs) in insomnia disorder. MAGIC Evidence Ecosystem Foundation. December 8, 2023. Accessed August 28, 2024. https:\/\/app.magicapp.org\/summary\/guideline_7882.html"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2830821\/shapoval_2025_oi_241671_1740068771.28401.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T16:03:37Z","timestamp":1741017817000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2830821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,3]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.59883","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,3]]}}}